Skip to main content

Idelalisib plus rituximab boosts survival in relapsed chronic lymphocytic leukemia

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Idelalisib plus rituximab boosts survival in relapsed chronic lymphocytic leukemia

User login

Username

Password

Reset your password

Type	Lead	score